278 related articles for article (PubMed ID: 8146891)
1. Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.
MacDonald KL; Mills WA; Wood RC; Hanson M; Kline W; Bowman RJ; Polesky HF; Williams AE; Osterholm MT
Transfusion; 1994 Mar; 34(3):202-8. PubMed ID: 8146891
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
4. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
5. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
6. Detection of antibody to hepatitis C virus by second-generation enzyme immunoassay.
Chaudhary RK; Maclean C
Am J Clin Pathol; 1993 Jun; 99(6):702-4. PubMed ID: 7686716
[TBL] [Abstract][Full Text] [Related]
7. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
Ann Intern Med; 1992 Sep; 117(6):470-5. PubMed ID: 1323944
[TBL] [Abstract][Full Text] [Related]
8. Low prevalence of hepatitis C virus infection among dentists in Taiwan.
Kuo MY; Hahn LJ; Hong CY; Kao JH; Chen DS
J Med Virol; 1993 May; 40(1):10-3. PubMed ID: 7685807
[TBL] [Abstract][Full Text] [Related]
9. Increased detection of hepatitis C virus (HCV)-infected blood donors by a multiple-antigen HCV enzyme immunoassay.
Kleinman S; Alter H; Busch M; Holland P; Tegtmeier G; Nelles M; Lee S; Page E; Wilber J; Polito A
Transfusion; 1992; 32(9):805-13. PubMed ID: 1471243
[TBL] [Abstract][Full Text] [Related]
10. Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays:justification and rational implementation.
Tobler LH; Tegtmeier G; Stramer SL; Quan S; Dockter J; Giachetti C; Busch MP
Transfusion; 2000 Jan; 40(1):15-24. PubMed ID: 10644807
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
[TBL] [Abstract][Full Text] [Related]
12. Blood donors who are repeatedly reactive for hepatitis C virus on enzyme immunoassay and positive on recombinant immunoblot assay: evidence of failure to identify some risk factors.
Moore SB; Kruger JR; Rakela J; Vamvakas EC; Schimek C; Germer JJ; Persing DH
Transfusion; 1995 Apr; 35(4):308-12. PubMed ID: 7701548
[TBL] [Abstract][Full Text] [Related]
13. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
14. Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
Caspari G; Gerlich WH; Beyer J; Schmitt H
Infusionsther Transfusionsmed; 1995 Aug; 22(4):208-19. PubMed ID: 7496119
[TBL] [Abstract][Full Text] [Related]
15. High rate of nonspecific anti-hepatitis C reactivity amongst homosexual men in comparison with that found in other sexually active groups and blood donors. Viral Hepatitis and AIDS Study Group.
Andreu J; Abad MA; Sanchez-Quijano A; Torronteras R; Luque F; Garcia de las Heras J; Soto B; Pineda JA; Leal M; Lissen E
J Intern Med; 1994 Jul; 236(1):73-7. PubMed ID: 7517430
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatitis C virus screening will reduce the incidence of post-transfusion hepatitis C also in low-risk areas.
Mathiesen UL; Ekermo B; Foberg U; Franzén L; Frydén A; Norlin R; Pettersson LG; Sterling H; Widell A; Bodemar G
Scand J Gastroenterol; 1992 Jun; 27(6):443-8. PubMed ID: 1321487
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus infection from blood and blood products.
van der Poel CL
FEMS Microbiol Rev; 1994 Jul; 14(3):241-6. PubMed ID: 7522022
[TBL] [Abstract][Full Text] [Related]
18. The use of a recombinant immunoblot assay in the interpretation of anti-hepatitis C virus reactivity among prospectively followed patients, implicated donors, and random donors.
Alter HJ; Tegtmeier GE; Jett BW; Quan S; Shih JW; Bayer WL; Polito A
Transfusion; 1991 Oct; 31(8):771-6. PubMed ID: 1656553
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to hepatitis C virus in autologous blood donors.
Conover PT; Fang CT; Lam E; Hirschler NV; Jackson JB; Yomtovian RA
Transfusion; 1991 Sep; 31(7):616-9. PubMed ID: 1654002
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.
González A; Esteban JI; Madoz P; Viladomiu L; Genesca J; Muñiz E; Enríquez J; Torras X; Hernández JM; Quer J
Hepatology; 1995 Aug; 22(2):439-45. PubMed ID: 7635410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
